Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
18.64
+0.19 (1.03%)
At close: Nov 4, 2024, 4:00 PM
18.69
+0.05 (0.27%)
After-hours: Nov 4, 2024, 7:29 PM EST

Teva Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
16,29015,84614,92515,87816,65916,887
Upgrade
Revenue Growth (YoY)
8.48%6.17%-6.00%-4.69%-1.35%-7.57%
Upgrade
Cost of Revenue
8,2278,2007,9528,2848,9339,351
Upgrade
Gross Profit
8,0637,6466,9737,5947,7267,536
Upgrade
Selling, General & Admin
3,5733,4983,4453,5283,6713,806
Upgrade
Research & Development
9919538389679971,010
Upgrade
Other Operating Expenses
1415282034
Upgrade
Operating Expenses
4,5784,4664,3114,5154,6714,820
Upgrade
Operating Income
3,4853,1802,6623,0793,0552,716
Upgrade
Interest Expense
-1,026-1,029-930-891-901-822
Upgrade
Interest & Investment Income
686810-10441
Upgrade
Earnings From Equity Investments
-12219138-13
Upgrade
Currency Exchange Gain (Loss)
-43-3016-72615
Upgrade
Other Non Operating Income (Expenses)
-17-66-62-69-63-56
Upgrade
EBT Excluding Unusual Items
2,4662,1251,7172,1212,3591,881
Upgrade
Merger & Restructuring Charges
-76-111-146-133-120-199
Upgrade
Impairment of Goodwill
-400-700-2,045--4,628-
Upgrade
Gain (Loss) on Sale of Investments
----90--
Upgrade
Gain (Loss) on Sale of Assets
282864581949
Upgrade
Asset Writedown
-925-378-402-584-1,918-1,778
Upgrade
Legal Settlements
-531-1,038-2,069-698-60-1,173
Upgrade
Other Unusual Items
-706-548-261-781-59
Upgrade
Pretax Income
-144-622-3,142667-4,267-1,279
Upgrade
Income Tax Expense
606-7-643211-168-278
Upgrade
Earnings From Continuing Operations
-750-615-2,499456-4,099-1,001
Upgrade
Minority Interest in Earnings
2975653-391092
Upgrade
Net Income
-453-559-2,446417-3,990-999
Upgrade
Net Income to Common
-453-559-2,446417-3,990-999
Upgrade
Shares Outstanding (Basic)
1,1241,1191,1101,1021,0951,091
Upgrade
Shares Outstanding (Diluted)
1,1241,1191,1101,1071,0951,091
Upgrade
Shares Change (YoY)
0.85%0.81%0.27%1.10%0.37%6.86%
Upgrade
EPS (Basic)
-0.40-0.50-2.200.38-3.64-0.92
Upgrade
EPS (Diluted)
-0.40-0.50-2.200.38-3.64-0.92
Upgrade
Free Cash Flow
6798421,042236638223
Upgrade
Free Cash Flow Per Share
0.600.750.940.210.580.20
Upgrade
Gross Margin
49.50%48.25%46.72%47.83%46.38%44.63%
Upgrade
Operating Margin
21.39%20.07%17.84%19.39%18.34%16.08%
Upgrade
Profit Margin
-2.78%-3.53%-16.39%2.63%-23.95%-5.92%
Upgrade
Free Cash Flow Margin
4.17%5.31%6.98%1.49%3.83%1.32%
Upgrade
EBITDA
4,5654,3333,9704,4094,6124,438
Upgrade
EBITDA Margin
28.02%27.34%26.60%27.77%27.68%26.28%
Upgrade
D&A For EBITDA
1,0801,1531,3081,3301,5571,722
Upgrade
EBIT
3,4853,1802,6623,0793,0552,716
Upgrade
EBIT Margin
21.39%20.07%17.84%19.39%18.34%16.08%
Upgrade
Effective Tax Rate
---31.63%--
Upgrade
Advertising Expenses
-162168246225213
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.